BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16275157)

  • 1. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.
    Zhou Y; Yu C; Miao X; Tan W; Liang G; Xiong P; Sun T; Lin D
    Carcinogenesis; 2004 Mar; 25(3):399-404. PubMed ID: 14604886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
    Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.
    Srivastava P; Lone TA; Kapoor R; Mittal RD
    Arch Med Res; 2012 Feb; 43(2):117-24. PubMed ID: 22374248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma.
    Miao X; Yu C; Tan W; Xiong P; Liang G; Lu W; Lin D
    Cancer Res; 2003 Jul; 63(14):3987-90. PubMed ID: 12873995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck.
    Li G; Liu Z; Sturgis EM; Shi Q; Chamberlain RM; Spitz MR; Wei Q
    Carcinogenesis; 2005 Sep; 26(9):1596-602. PubMed ID: 15878916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.
    Yu C; Pan K; Xing D; Liang G; Tan W; Zhang L; Lin D
    Cancer Res; 2002 Nov; 62(22):6430-3. PubMed ID: 12438229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
    Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
    Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
    Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
    Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
    Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
    Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
    Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
    Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
    Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease.
    Gai X; Zhang Z; Liang Y; Chen Z; Yang X; Hou J; Lan X; Zheng W; Hou J; Huang M
    Clin Chim Acta; 2010 May; 411(9-10):719-24. PubMed ID: 20138860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
    Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
    Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk.
    Peng B; Cao L; Ma X; Wang W; Wang D; Yu L
    Mutagenesis; 2010 Jul; 25(4):371-9. PubMed ID: 20360147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haplotypes of two variants in p16 (CDKN2/MTS-1/INK4a) exon 3 and risk of squamous cell carcinoma of the head and neck: a case-control study.
    Zheng Y; Shen H; Sturgis EM; Wang LE; Shete S; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):640-5. PubMed ID: 12101111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase 5'- and 3'-untranslated region polymorphisms associated with risk and progression of squamous cell carcinoma of the head and neck.
    Zhang Z; Shi Q; Sturgis EM; Spitz MR; Hong WK; Wei Q
    Clin Cancer Res; 2004 Dec; 10(23):7903-10. PubMed ID: 15585623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.